文献速递头颈部肿瘤放疗姑息放疗与转移瘤

放射剂量对头颈部髓外浆细胞瘤局部控制与生存的影响

Impact of radiation dose on local control and survival in extramedullary head and neck plasmacytoma.
PubMed 文献 · Radiat Oncol · 2019-04-15

该研究回顾了2005年1月至2017年1月在本机构接受放疗的27例头颈部髓外浆细胞瘤(EMP)患者,共33个放疗疗程,中位剂量45 Gy(范围12-55.8 Gy)。原发EMP的局部控制率(93% vs 61%,P<0.05)和完全缓解率(67% vs 22%,P<0.01)均优于继发性EMP病变。高剂量(>45 Gy)组中位生存显著长于低剂量(≤45 Gy)组(P=0.02),但原发EMP亚组中高剂量与低剂量在总缓解率、局部控制时长和生存上均无显著差异。

要点

  • 原发EMP的局部控制率93%、完全缓解率67%,均显著优于继发性EMP病变(61%、22%)。
  • 高剂量(>45 Gy)组中位生存显著长于低剂量(≤45 Gy)组(P=0.02)。
  • 原发EMP亚组中高剂量与低剂量在总缓解率、局部控制时长和生存上均无显著差异。

核心结论

  • 放疗是治疗髓外浆细胞瘤的有效手段。
  • ≤45 Gy的放射剂量可获得与高剂量方案相当的完全缓解率,似乎能有效控制局部EMP进展。
  • 放射剂量提升可能对特定亚组患者有益。

研究设计与样本

  • 回顾性分析2005年1月至2017年1月在本机构接受放疗的27例头颈部髓外浆细胞瘤患者,共33个放疗疗程,中位年龄56岁,中位放疗剂量45 Gy(范围12-55.8 Gy)。

主要发现

  • 局部控制率为76%(原发EMP 93% vs 继发性EMP病变61%;P<0.05)。
  • 局部放疗的完全缓解率为42%(原发EMP 67% vs 继发性EMP病变22%;P<0.01)。
  • 高剂量(>45 Gy)组与低剂量(≤45 Gy)组的总缓解率分别为87%和67%(P=0.2)。
  • 高剂量放疗组的中位生存显著更长(P=0.02)。
  • 原发EMP亚组中,高剂量组与低剂量组的总缓解率分别为100%和80%(P=0.3),局部控制时长(P=0.3)和生存(P=0.05)均无显著差异;继发性EMP患者中,高剂量组与低剂量组的总缓解率分别为60%和62%(P=1),生存(P=0.4)无显著差异。

临床怎么用

  • 原文结论认为放疗是治疗EMP的有效手段,≤45 Gy的剂量可获得与高剂量方案相当的完全缓解率,似乎能有效控制局部EMP进展。
  • 原文结论提出放射剂量提升可能对特定亚组患者有益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with plasma-cell neoplasia usually suffer from systemic disease, although a minority (< 5%) may present with solitary involvement of bone or soft tissue (extramedullary plasmacytoma (EMP)). Radiotherapy (RT) is a state-of-the-art treatment for these tumors offering long term curation. METHODS AND MATERIALS: Between January 2005 and January 2017, twenty-seven patients underwent RT at our institution. The aim of this study was to analyse the effectiveness of various RT doses for different forms of EMP. RESULTS: A total of 33 radiation courses were administered to 27 patients with a median age of 56 years. The median RT dose was 45 Gy (range: 12-55.8). The local control rate was 76% (93% for primary EMP vs. 61% for the secondary EMP lesions; P < 0.05). A complete response (CR) rate to local RT was achieved for 42% lesions (67% for primary EMP vs. 22% for the secondary EMP lesions; P < 0.01). The overall response rate (ORR) for the EMP lesions treated with high-dose regimens (> 45 Gy) versus low-dose regimens (≤ 45 Gy) was 87% versus 67%, respectively (P = 0.2). The median survival with high-dose RT group was significantly longer (P = 0.02). In subgroups analysis, primary EMP patients treated with high-dose RT had a non-significant higher ORR (100% vs. 80%, respectively; P = 0.3,) longer duration of LC (P = 0.3) with a longer survival (P = 0.05) than patients in low-dose group. No significant difference has been detected in secondary EMP patients treated with high-dose RT regarding ORR (60% vs. 62%, respectively; P = 1), and survival (P = 0.4). CONCLUSION: RT is an efficacious treatment modality in the treatment of EMP. A radiation dose ≤45 Gy confer a comparable CR rate to high-dose regimens and appears to be an effective treatment for controlling local EMP progression. Radiation dose-escalation may be beneficial for particular subgroups of patients.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Oertel M, Elsayad K, Kroeger KJ, et al. Impact of radiation dose on local control and survival in extramedullary head and neck plasmacytoma. Radiat Oncol. 2019. PMID: 30987659. doi:10.1186/s13014-019-1265-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。